Category: Vaccines

December 3, 2021

Lab studies show that the mutations found in COVID-19’s Delta variant make the virus more resistant to existing vaccines, a potentially ominous development as the new Omicron variant starts to wend its way around the world. Full vaccination with the […]

December 3, 2021

The vaccine industry recognized the potential of mRNA vaccines as far back as the 1980s.1 It anticipated that mRNA molecules could be synthesized in large quantities more quickly and cheaply than proteins.2 And it also knew that mRNA vaccines would […]

December 3, 2021

Vaccines are among the hottest topics in biopharmaceuticals today. At the time of this article’s writing, 49.5% of the world’s population have already received at least one dose of a COVID-19 vaccine, and 26.65 million doses are being administered each […]

December 2, 2021

Sanofi has announced that it entered into an agreement to acquire Origimm Biotechnology, an Austrian privately owned biotechnology company specialising in the discovery of virulent skin microbiome components and antigens from bacteria causing skin disease, such as acne. The transaction […]

December 1, 2021

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of […]

November 30, 2021

Attention is turning to the vaccines that most developed countries are relying on to control the COVID-19 pandemic, asking two key questions: will the existing vaccines work against Omicron and, iIf not, how quickly can manufacturers ‘tweak’ them to boost […]

November 30, 2021

As the world assesses the threat posed by the COVID-19 omicron variant, two top companies producing pandemic drugs and vaccines have warned that their current offerings may not be effective against the variant. On Tuesday, Regeneron sounded (PDF) a disquieting […]

November 30, 2021

Pfizer Inc. is expected to seek approval this week for emergency use of its booster shots among American teens ages 16-17. Sources familiar with the matter told The New York Times that the U.S. Food and Drug Administration could give […]

November 29, 2021

With the new omicron strain fueling fear around the globe that the coronavirus is regaining momentum, makers of the world’s most successful vaccines are investigating whether they need to tweak their shots. Over the last few days, Moderna, Pfizer-BioNTech, Johnson […]

November 29, 2021

Companies are testing their COVID-19 vaccines against the new variant, omicron. An FDA advisory committee will meet tomorrow to discuss its recommendation for Merck’s COVID-19 antiviral. The worldwide case count stood at more than 261.98 million Monday afternoon, with more […]

November 19, 2021

The race between Moderna and Pfizer to gain FDA nods for their COVID-19 vaccines as boosters in all adults has ended in a dead heat. On Friday morning, the FDA simultaneously expanded emergency use authorizations for both mRNA vaccines to […]

November 19, 2021

Two COVID-19 mRNA vaccines, made by BioNTech/Pfizer and Moderna, are helping to change the course of the COVID-19 pandemic. A third mRNA vaccine, developed by CureVac and known as CVnCoV, has not had the same success to date. Indeed, a […]